Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 22

Trial Status

Completed1
Other3

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT07173153Phase 1/2Enrolling By Invitation
Gene Therapy for SLC6A1 Neurodevelopmental Disorder
SLC6A1
PrincipalinvestigatorStart date: 2025-08-25
NCT04273243Active Not Recruiting
Long-Term Follow Up of CLN6 Batten Disease Subjects Following Gene Transfer
Batten DiseaseCLN6
PrincipalinvestigatorStart date: 2020-01-24
NCT03862274Enrolling By Invitation
Examining Developmental Outcomes of Children Diagnosed With CLN2 Disease
Batten DiseaseCLN2Neuronal Ceroid-Lipofuscinoses
PrincipalinvestigatorStart date: 2018-12-01
NCT02725580Phase 1/2Completed
Gene Therapy For Children With Variant Late Infantile Neuronal Ceroid Lipofuscinosis 6 (vLINCL6) Disease
Variant Late-Infantile Neuronal Ceroid Lipofuscinosis
PrincipalinvestigatorStart date: 2016-05-01

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jessica Scherr, PhD

Nationwide Children's Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Juvenile Neuronal Ceroid LipofuscinosisCLN2Neuronal Ceroid-Lipofuscinoses

Worked with same sponsors:

BioMarin PharmaceuticalJessica Scherr
Collaborated on 1 trial
Similarity Score34%

Angela Schulz, MD, PhD

Head of NCL-Specialty Clinic

Related
1 trials

Shared therapeutic areas:

Juvenile Neuronal Ceroid LipofuscinosisNeuronal Ceroid-Lipofuscinoses
Similarity Score10%

Emily de los Reyes, MD

Abigail Wexner Research Institute, Nationwide Children's Hospital

Related
1 trials

Shared therapeutic areas:

Juvenile Neuronal Ceroid LipofuscinosisCLN6

Worked with same sponsors:

Emily de los Reyes
Similarity Score10%

Jonathan W Mink, MD PhD

University of Rochester

Related
1 trials

Shared therapeutic areas:

Juvenile Neuronal Ceroid LipofuscinosisNeuronal Ceroid-Lipofuscinoses
Similarity Score10%

Robert Steiner, MD

Oregon Health and Science University

Related
1 trials

Shared therapeutic areas:

Neuronal Ceroid-Lipofuscinoses
Similarity Score5%

Ronald G. Crystal, MD

Weill Medical College of Cornell University

Related
3 trials

Shared therapeutic areas:

Juvenile Neuronal Ceroid Lipofuscinosis
Similarity Score5%

An N Dang Do, M.D.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Related
4 trials

Shared therapeutic areas:

Juvenile Neuronal Ceroid Lipofuscinosis
Similarity Score5%

Laura Andres-Martin, PhD

New York Stem Cell Foundation Research Institute

Related
2 trials

Shared therapeutic areas:

Juvenile Neuronal Ceroid Lipofuscinosis
Similarity Score5%

Nathan Selden, MD, PhD

Oregon Health and Science University

Related
1 trials

Shared therapeutic areas:

Neuronal Ceroid-Lipofuscinoses
Similarity Score5%

Mitchell S Cairo, MD

New York Medical College

Related
13 trials

Shared therapeutic areas:

Juvenile Neuronal Ceroid Lipofuscinosis
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT07173153Phase 1/2PrincipalInvestigator

Gene Therapy for SLC6A1 Neurodevelopmental Disorder

SLC6A1
Enrolling By Invitation
NCT04273243PrincipalInvestigator

Long-Term Follow Up of CLN6 Batten Disease Subjects Following Gene Transfer

Batten DiseaseCLN6
Active Not Recruiting
NCT03862274PrincipalInvestigator

Examining Developmental Outcomes of Children Diagnosed With CLN2 Disease

Batten DiseaseCLN2Neuronal Ceroid-Lipofuscinoses
Enrolling By Invitation
NCT02725580Phase 1/2PrincipalInvestigator

Gene Therapy For Children With Variant Late Infantile Neuronal Ceroid Lipofuscinosis 6 (vLINCL6) Disease

Variant Late-Infantile Neuronal Ceroid Lipofuscinosis
Completed

All 4 trials loaded